CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Fundação Pio XII (FP). Hospital do Câncer de Barretos (Institutional affiliation from the last research proposal) Birthplace: Brazil
Silvia Aparecida Teixeira in research grants and scholarships supported by FAPESP.
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Ependymomas are the third most common type of brain tumor in children, remaining incurable at the time of recurrence. These tumors can arise throughout the neuroaxis, including the supratentorial brain, posterior fossa, and spinal cord. While they affect both adults and children, posterior fossa tumors are more common in children, whereas supratentorial and spinal tumors prevail in adults…
Ependymomas (EPNs) are rare tumors of the central nervous system that originate from the ependymal cells of the cerebral ventricles, the central canal of the spinal cord, or cortical rests. These tumors can occur in both adults and children; however, pediatric patients have a more unfavorable prognosis, with a recurrence rate of 74% within 1.5 years. EPNs are a heterogeneous group of tumo…
Medulloblastoma (MB), a malignant tumor originating in the cerebellum, represents 20% of tumors of the Central Nervous System in infants, children, and young adults. Specifically, for medulloblastomas associated with the Hedgehog signaling pathway (SHH), research has shown that host cells in the tumor microenvironment influence the biological behavior of tumor cells, contributing to the p…
Glioblastoma is the most common and aggressive of primary brain tumors. Despite technological advances in the surgical procedure, followed by radiotherapy and chemotherapy, the average survival of patients is 12 to 15 months. This type of tumor has high cellular heterogeneity, with complex genetic alterations that reflect high genomic instability and have persistent malignant progression,…
The treatment of glioblastoma (GBM) remains a major challenge for clinicians since these highly aggressive brain tumors are highly resistant to radio- and chemotherapy, and recurrence is practically inevitable. The poor prognosis of GBM patients is in part due to the presence of a heterogeneous population of glioblastoma stem cells (GSCs) within the tumor, characterized by invasive behavi…
| 2 / 2 | Ongoing scholarships in Brazil |
| 3 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 6 / 5 | All Scholarships |
| Associated processes | |